$PZG
Paramount Gold Nevada Corp

2021 Q1 Form 10-Q Financial Statement

#000156459021025259 Filed on May 07, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q3 2020 Q1
Revenue $0.00 $68.95K $391.5K
YoY Change -100.0% 119.87% 84.02%
Cost Of Revenue $130.3K $131.2K $131.6K
YoY Change -1.03% -4.65% 0.83%
Gross Profit -$130.3K -$62.23K $259.9K
YoY Change -150.13% -41.41% 216.13%
Gross Profit Margin -90.25% 66.38%
Selling, General & Admin $518.2K $495.2K $417.1K
YoY Change 24.24% 43.74% -11.48%
% of Gross Profit 160.51%
Research & Development $590.3K $636.0K $1.068M
YoY Change -44.73% 38.7% 49.87%
% of Gross Profit 411.0%
Depreciation & Amortization $624.00 $630.00 $650.00
YoY Change -4.0% 36.96% 0.0%
% of Gross Profit 0.25%
Operating Expenses $1.254M $1.147M $1.711M
YoY Change -26.7% 32.98% 22.98%
Operating Profit -$1.254M -$1.209M -$1.320M
YoY Change -4.96% 21.85% 11.97%
Interest Expense -$100.1K -$122.5K -$120.5K
YoY Change -16.95% -877.19% -2331.48%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.354M -$1.332M -$1.440M
YoY Change -5.96% 32.29% 22.75%
Income Tax
% Of Pretax Income
Net Earnings -$1.354M -$1.332M -$1.440M
YoY Change -5.96% 32.29% 22.75%
Net Earnings / Revenue -1931.12% -367.92%
Basic Earnings Per Share -$0.04
Diluted Earnings Per Share -$0.04 -$39.48K -$51.86K
COMMON SHARES
Basic Shares Outstanding 36.32M 33.94M
Diluted Shares Outstanding 36.32M

Balance Sheet

Concept 2021 Q1 2020 Q3 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.607M $4.491M $1.414M
YoY Change 225.76% 7.26% 290.71%
Cash & Equivalents $4.607M $4.491M $1.414M
Short-Term Investments
Other Short-Term Assets $18.18K $721.9K $770.9K
YoY Change -97.64% -56.21% 86.95%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $5.105M $5.213M $2.185M
YoY Change 133.63% -10.67% 182.21%
LONG-TERM ASSETS
Property, Plant & Equipment $47.34M $47.34M $47.06M
YoY Change 0.59% 810674.96% -3.69%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $463.0K $633.1K $693.0K
YoY Change -33.2% -54.22% -50.77%
Total Long-Term Assets $47.80M $47.97M $47.76M
YoY Change 0.1% -0.97% -5.01%
TOTAL ASSETS
Total Short-Term Assets $5.105M $5.213M $2.185M
Total Long-Term Assets $47.80M $47.97M $47.76M
Total Assets $52.91M $53.19M $49.94M
YoY Change 5.94% -2.01% -2.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $461.0K $508.4K $627.0K
YoY Change -26.48% -35.2% -4.43%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $536.0K $599.4K $724.3K
YoY Change -26.0% -32.02% -4.41%
LONG-TERM LIABILITIES
Long-Term Debt $4.182M $5.117M $5.239M
YoY Change -20.17% -1.68%
Other Long-Term Liabilities $336.1K $476.0K $216.1K
YoY Change 55.58% -45.06% -69.31%
Total Long-Term Liabilities $4.519M $5.593M $5.455M
YoY Change -17.17% -7.87% 674.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $536.0K $599.4K $724.3K
Total Long-Term Liabilities $4.519M $5.593M $5.455M
Total Liabilities $5.055M $6.193M $6.179M
YoY Change -18.2% -10.93% 322.73%
SHAREHOLDERS EQUITY
Retained Earnings -$58.59M
YoY Change
Common Stock $106.4M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $47.85M $47.00M $43.76M
YoY Change
Total Liabilities & Shareholders Equity $52.91M $53.19M $49.94M
YoY Change 5.94% -2.01% -2.17%

Cashflow Statement

Concept 2021 Q1 2020 Q3 2020 Q1
OPERATING ACTIVITIES
Net Income -$1.354M -$1.332M -$1.440M
YoY Change -5.96% 32.29% 22.75%
Depreciation, Depletion And Amortization $624.00 $630.00 $650.00
YoY Change -4.0% 36.96% 0.0%
Cash From Operating Activities -$1.129M -$1.713M -$591.7K
YoY Change 90.81% 15.91% -34.19%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$1.280K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 -$1.280K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $770.5K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.238M 770.5K 0.000
YoY Change -85.19% -100.0%
NET CHANGE
Cash From Operating Activities -1.129M -1.713M -591.7K
Cash From Investing Activities 0.000 0.000 -1.280K
Cash From Financing Activities 2.238M 770.5K 0.000
Net Change In Cash 1.109M -942.6K -593.0K
YoY Change -287.05% -125.31% -1059.7%
FREE CASH FLOW
Cash From Operating Activities -$1.129M -$1.713M -$591.7K
Capital Expenditures $0.00 -$1.280K
Free Cash Flow -$1.129M -$590.4K
YoY Change 91.22% -34.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
18182
CY2020Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
5256228
CY2021Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4518557
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5752795
CY2021Q1 us-gaap Liabilities
Liabilities
5054549
CY2020Q2 us-gaap Liabilities
Liabilities
6832286
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
373133
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
329584
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
106071651
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
100881957
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58591203
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54130329
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
47853581
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
47081212
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52908130
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53913498
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37313267
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32958404
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37313267
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32958404
us-gaap Other Income
OtherIncome
254800
us-gaap Exploration Expense
ExplorationExpense
3335221
pzg Land Holding Costs
LandHoldingCosts
401346
us-gaap Professional Fees
ProfessionalFees
124809
us-gaap Labor And Related Expense
LaborAndRelatedExpense
740369
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
64499
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
423736
us-gaap General Insurance Expense
GeneralInsuranceExpense
103286
us-gaap Depreciation
Depreciation
2096
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
70942
us-gaap Operating Expenses
OperatingExpenses
5266304
us-gaap Operating Income Loss
OperatingIncomeLoss
-4537394
us-gaap Investment Income Interest
InvestmentIncomeInterest
14466
pzg Interest And Service Charges
InterestAndServiceCharges
266460
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
47329742
CY2020 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
976144
CY2020 pzg Stock Issued During Period Value Payment Of Interest Accrued
StockIssuedDuringPeriodValuePaymentOfInterestAccrued
119309
CY2020 pzg Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
4882966
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
77424
CY2020Q3 pzg Stock Issued During Period Value Payment Of Interest Accrued
StockIssuedDuringPeriodValuePaymentOfInterestAccrued
205413
CY2020Q3 pzg Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
770514
CY2020Q3 pzg Stock Issued During Period Value Conversion Of Debt
StockIssuedDuringPeriodValueConversionOfDebt
192066
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1331508
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
46995121
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
201465
CY2020Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
181458
CY2020Q4 pzg Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
126842
CY2020Q4 pzg Stock Issued During Period Value Conversion Of Debt
StockIssuedDuringPeriodValueConversionOfDebt
337783
CY2020Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1774899
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
46067770
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
80864
CY2021Q1 pzg Stock Issued During Period Value Payment Of Interest Accrued
StockIssuedDuringPeriodValuePaymentOfInterestAccrued
193364
CY2021Q1 pzg Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
2238270
CY2021Q1 pzg Stock Issued During Period Value Conversion Of Debt
StockIssuedDuringPeriodValueConversionOfDebt
627780
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1354467
us-gaap Profit Loss
ProfitLoss
-4460874
us-gaap Profit Loss
ProfitLoss
-4789388
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4607317
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
181458
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
976144
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
359753
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
127012
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
47868
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
37225
pzg Interest Expense Income
InterestExpenseIncome
278155
pzg Interest Expense Income
InterestExpenseIncome
-102425
pzg Interest Earned On Reclamation Bond
InterestEarnedOnReclamationBond
16968
pzg Interest Earned On Reclamation Bond
InterestEarnedOnReclamationBond
14447
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
18182
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
37187
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
422089
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-343327
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-131540
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3962390
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4246470
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
4719
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4719
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3135626
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
5201807
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3135626
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5201807
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-826764
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
950618
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5434081
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
463690
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1414308
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
332836
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
49408
CY2020Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
615170
CY2019Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
965677
CY2020 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
94591
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
166792
CY2020Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.10
CY2020Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
362427
us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
249057
CY2020 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
723279
CY2020 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
278181
CY2020Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
362427
CY2020Q2 pzg Fair Value Of Shares Issued
FairValueOfSharesIssued
398777
CY2020Q4 pzg Fair Value Of Shares Issued
FairValueOfSharesIssued
398777
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.51
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.57
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.50
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.61
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
218173
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P11M4D
CY2020Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1096791
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1096791
CY2020Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.89
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
943992
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
755000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
664994
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1033998
CY2021Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
411143
us-gaap Accretion Expense
AccretionExpense
45030
us-gaap Accretion Expense
AccretionExpense
70942
us-gaap Insurance Recoveries
InsuranceRecoveries
249057
CY2020Q1 us-gaap Insurance Recoveries
InsuranceRecoveries
391492
us-gaap Insurance Recoveries
InsuranceRecoveries
723279
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
5743
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
5631
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
2644
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
41951

Files In Submission

Name View Source Status
0001564590-21-025259-index-headers.html Edgar Link pending
0001564590-21-025259-index.html Edgar Link pending
0001564590-21-025259.txt Edgar Link pending
0001564590-21-025259-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pzg-10q_20210331.htm Edgar Link pending
pzg-20210331.xml Edgar Link completed
pzg-20210331.xsd Edgar Link pending
pzg-20210331_cal.xml Edgar Link unprocessable
pzg-20210331_def.xml Edgar Link unprocessable
pzg-20210331_lab.xml Edgar Link unprocessable
pzg-20210331_pre.xml Edgar Link unprocessable
pzg-ex311_9.htm Edgar Link pending
pzg-ex312_6.htm Edgar Link pending
pzg-ex321_8.htm Edgar Link pending
pzg-ex322_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending